Literature DB >> 1846487

The Vmw175 binding site in the IE-1 promoter has no apparent role in the expression of Vmw110 during herpes simplex virus type 1 infection.

R D Everett1, A Orr.   

Abstract

The immediate-early (IE) genes of herpes simplex virus type 1 (HSV-1) are the first to be expressed during infection in tissue culture. Since they are transcribed at abnormally high levels in the absence of IE protein synthesis they appear to be subject to repression during normal infection. One of the major HSV-1 regulatory proteins, Vmw175 (the product of IE gene 3), is required for normal IE gene regulation since mutations which inactivate it lead to abnormally high levels of IE gene expression. The mechanism of repression of the IE-3 promoter requires both the ability of Vmw175 to bind to DNA and the presence of a Vmw175 recognition DNA binding sequence at the cap site of the IE-3 promoter. A similar Vmw175 DNA binding sequence has been defined within the IE-1 promoter. This paper describes the construction of a variant of HSV-1 with a mutation within the IE-1 Vmw175 DNA binding site. Although the mutation destroyed the ability of Vmw175 to bind to the site, and greatly reduced the ability of Vmw175 to repress the IE-1 promoter in transfection assays, the mutation had no effect on the levels of Vmw110 expression during normal HSV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846487     DOI: 10.1016/0042-6822(91)90064-i

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Role of alpha-transinducing factor (VP16) in the induction of alpha genes within the context of viral genomes.

Authors:  D Spector; F Purves; B Roizman
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Differential dependence of herpes simplex virus immediate-early gene expression on de novo-infected cell protein synthesis.

Authors:  N A Elshiekh; E Harris-Hamilton; S L Bachenheimer
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome.

Authors:  M Lagunoff; B Roizman
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Repression of the herpes simplex virus 1 alpha 4 gene by its gene product occurs within the context of the viral genome and is associated with all three identified cognate sites.

Authors:  N Michael; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  Repression of the herpes simplex virus 1 alpha 4 gene by its gene product (ICP4) within the context of the viral genome is conditioned by the distance and stereoaxial alignment of the ICP4 DNA binding site relative to the TATA box.

Authors:  R Leopardi; N Michael; B Roizman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Binding sites for the herpes simplex virus immediate-early protein ICP4 impose an increased dependence on viral DNA replication on simple model promoters located in the viral genome.

Authors:  K E Koop; J Duncan; J R Smiley
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4.

Authors:  F Yao; P A Schaffer
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection.

Authors:  E K Lium; C A Panagiotidis; X Wen; S Silverstein
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Purification of the DNA binding domain of herpes simplex virus type 1 immediate-early protein Vmw175 as a homodimer and extensive mutagenesis of its DNA recognition site.

Authors:  R D Everett; M Elliott; G Hope; A Orr
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene.

Authors:  Mingyu Liu; Brandon Rakowski; Edward Gershburg; Carla M Weisend; Olivier Lucas; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.